Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;304(1):5-38.
doi: 10.1007/s00404-021-06049-z. Epub 2021 Apr 2.

A systematic review of pregnant women with COVID-19 and their neonates

Mona Mirbeyk  1   2 , Amene Saghazadeh  1   2 , Nima Rezaei  3   4   5   6
Affiliations

A systematic review of pregnant women with COVID-19 and their neonates

Mona Mirbeyk et al. Arch Gynecol Obstet. 2021 Jul.

Abstract

Background: In December 2019, a novel coronavirus disease (COVID-19) emerged in Wuhan, China, with an incredible contagion rate. However, the vertical transmission of COVID-19 is uncertain.

Objectives: This is a systematic review of published studies concerning pregnant women with confirmed COVID-19 and their neonates.

Search strategy: We carried out a systematic search in multiple databases, including PubMed, Web of Science, Google Scholar, Scopus, and WHO COVID-19 database using the following keywords: (Coronavirus) OR (novel coronavirus) OR (COVID-19) OR (COVID19) OR (COVID 19) OR (SARS-CoV2) OR (2019-nCoV)) and ((pregnancy) OR (pregnant) OR (vertical transmission) OR (neonate) OR (newborn) OR (placenta) OR (fetus) OR (Fetal)). The search took place in April 2020.

Selection criteria: Original articles published in English were eligible if they included pregnant patients infected with COVID-19 and their newborns.

Data collection and analyses: The outcomes of interest consisted of clinical manifestations of COVID-19 in pregnant patients with COVID-19 and also the effect of COVID-19 on neonatal and pregnancy outcomes.

Main results: 37 articles involving 364 pregnant women with COVID-19 and 302 neonates were included. The vast majority of pregnant patients were in their third trimester of pregnancy, and only 45 cases were in the first or second trimester (12.4%). Most mothers described mild to moderate manifestations of COVID-19. Of 364 pregnant women, 25 were asymptomatic at the time of admission. The most common symptoms were fever (62.4%) and cough (45.3%). Two maternal deaths occurred. Some pregnant patients (12.1%) had a negative SARS-CoV-2 test but displayed clinical manifestations and abnormalities in computed tomography (CT) scan related to COVID-19. Twenty-two (6.0%) pregnant patients developed severe pneumonia. Two maternal deaths occurred from severe pneumonia and multiple organ dysfunction. Studies included a total of 302 neonates from mothers with COVID-19. Of the studies that provided data on the timing of birth, there were 65 (23.6%) preterm neonates. One baby was born dead from a mother who also died from COVID-19. Of the babies born alive from mothers with COVID-19, five newborns faced critical conditions, and two later died. A total of 219 neonates underwent nasopharyngeal specimen collection for SARS-CoV-2, of which 11 tested positive (5%). Seventeen studies examined samples of the placenta, breast milk, umbilical cord, and amniotic fluid, and all tested negative except one amniotic fluid sample.

Conclusions: A systematic review of published studies confirm that the course of COVID-19 in pregnant women resembles that of other populations. However, there is not sufficient evidence to establish an idea that COVID-19 would not complicate pregnancy.

Keywords: COVID-19; Immunity; Neonates; Pregnancy; SARS-CoV2; Vertical transmission.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have co conflicts of interest.

Figures

Fig. 1
Fig. 1
PRISMA flowchart of the literature search
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Hanaei S, Rezaei N. COVID-19: developing from an outbreak to a pandemic. Arch Med Res. 2020;51(6):582–584. doi: 10.1016/j.arcmed.2020.04.021. - DOI - PMC - PubMed
    1. Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. 2020;20(7):773. doi: 10.1016/S1473-3099(20)30195-X. - DOI - PMC - PubMed
    1. Hessami A, Shamshirian A, Heydari K, Pourali F, Alizadeh-Navaei R, Moosazadeh M, Abrotan S, Shojaie L, Sedighi S, Shamshirian D, Rezaei N. Cardiovascular diseases burden in COVID-19: systematic review and meta-analysis. Am J Emerg Med. 2020 doi: 10.1016/j.ajem.2020.10.022. - DOI - PMC - PubMed
    1. Jabalameli N, Rajabi F, Firooz A, Rezaei N. The overlap between genetic susceptibility to COVID-19 and skin diseases. Immunol Invest. 2021 doi: 10.1080/08820139.2021.1876086. - DOI - PubMed
    1. Jahanshahlu L, Rezaei N. Central nervous system involvement in COVID-19. Arch Med Res. 2020;51(7):721–722. doi: 10.1016/j.arcmed.2020.05.016. - DOI - PMC - PubMed

Publication types